Cancer susceptibility candidate 9 (CASC9) has been found to be upregulated in hepatocellular carcinoma compared to normal healthy controls and levels of expression in HCC may also be predictive of metastasis and prognosis [133]. Here, CASC9 is linked to hepatocellular carcinoma.